{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:18:44Z","timestamp":1789892324700,"version":"4.0.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"vor","delay-in-days":164,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.bjid.2013.01.007","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T04:45:25Z","timestamp":1362804325000},"page":"239-246","source":"Crossref","is-referenced-by-count":17,"title":["Multidrug-resistant tuberculosis"],"prefix":"10.1016","volume":"17","author":[{"given":"Ant\u00f4nio Carlos Moreira","family":"Lemos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana Dias","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2013.01.007_bib0005","series-title":"Gu\u00eda de la tuberculosis para M\u00e9dicos Especialistas","author":"Caminero Luna","year":"2003"},{"key":"10.1016\/j.bjid.2013.01.007_bib0010","series-title":"Guidelines for the programmatic management of drug-resistant tuberculosis \u2013 emergency update","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.bjid.2013.01.007_bib0015","series-title":"Global tuberculosis control: short update to 2009 report","author":"WHO","year":"2009"},{"key":"10.1016\/j.bjid.2013.01.007_bib0020","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3201\/eid1209.051618","article-title":"Multidrug-resistant tuberculosis management in resource-limited settings","volume":"12","author":"Nathanson","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0025","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/jama.1991.03470110027006","article-title":"Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons \u2013 Florida and New York, 1988\u20131991","volume":"266","author":"Centers for Disease Control","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.bjid.2013.01.007_bib0030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJM199302253280801","article-title":"The emergence of drug-resistant tuberculosis in New York City","volume":"328","author":"Frieden","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2013.01.007_bib0035","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/514084","article-title":"Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires","volume":"176","author":"Ritacco","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3201\/eid0202.960208","article-title":"Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain","volume":"2","author":"Rull\u00e1n","year":"1996","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0045","series-title":"Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.bjid.2013.01.007_bib0050","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2013.01.007_bib0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2471\/BLT.11.092585","article-title":"Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007\u20132010","volume":"90","author":"Zignol","year":"2012","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.bjid.2013.01.007_bib0060","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. II Inqu\u00e9rito Nacional de Resist\u00eancia aos F\u00e1rmacos anti-TB, 2007\u20132008, dados n\u00e3o publicados."},{"key":"10.1016\/j.bjid.2013.01.007_bib0065","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/AEM.20.5.810-814.1970","article-title":"Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis","volume":"20","author":"David","year":"1970","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.bjid.2013.01.007_bib0070","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1086\/517536","article-title":"Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance","volume":"44","author":"Cox","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2958.2003.03315.x","article-title":"Linkage disequilibrium between minisatellite loci supports clonal evolution of Mycobacterium tuberculosis in a high tuberculosis incidence area","volume":"47","author":"Supply","year":"2003","journal-title":"Mol Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.bjid.2013.01.007_bib0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1590\/S0034-89102007000800006","article-title":"Tuberculose multirresistente no Brasil: hist\u00f3rico e medidas de controle","volume":"41","author":"Dalcolmo","year":"2007","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.bjid.2013.01.007_bib0085","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/358591a0","article-title":"The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis","volume":"358","author":"Zhang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bjid.2013.01.007_bib0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0923-2508(93)90029-2","article-title":"Genetic basis of isoniazid resistance of Mycobacterium tuberculosis","volume":"144","author":"Zhang","year":"1993","journal-title":"Res Microbiol"},{"key":"10.1016\/j.bjid.2013.01.007_bib0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2958.1995.tb02238.x","article-title":"Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis","volume":"15","author":"Heym","year":"1995","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bjid.2013.01.007_bib0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijantimicag.2003.10.004","article-title":"Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East","volume":"23","author":"Ahmad","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2013.01.007_bib0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/171.1.237","article-title":"Catalase expression, katG, and MIC of isoniazid for Mycobacterium tuberculosis isolates from Sao Paulo, Brazil","volume":"171","author":"Ferrazoli","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/mcpr.1995.0066","article-title":"KatG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates","volume":"9","author":"Goto","year":"1995","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.bjid.2013.01.007_bib0115","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/JCM.41.9.4471-4474.2003","article-title":"Mutations in KatG, inhA and ahpC genes of Brazilian isoniazid resistant isolates of Mycobacterium tuberculosis","volume":"41","author":"Silva","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2013.01.007_bib0120","first-page":"87","article-title":"Prevalence of katG Ser315 Mycobacterium tuberculosis isolates from Brazil","volume":"9","author":"Hofling","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0125","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/jcp.49.11.945","article-title":"Presence of katG gene in resistant Mycobacterium tuberculosis","volume":"49","author":"Jaber","year":"1996","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bjid.2013.01.007_bib0130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"InhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bjid.2013.01.007_bib0135","first-page":"508","article-title":"Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis","volume":"17","author":"Rinder","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0272-5231(05)70355-5","article-title":"Genetics of drug resistance in tuberculosis","volume":"18","author":"Telenti","year":"1997","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.bjid.2013.01.007_bib0145","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1128\/JCM.41.7.3384-3386.2003","article-title":"Low-stringency single-specificprimer PCR as a tool for detection of mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis","volume":"41","author":"Carvalho","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2013.01.007_bib0150","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1128\/AAC.49.6.2200-2209.2005","article-title":"Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis","volume":"49","author":"McCammon","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2013.01.007_bib0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jac\/34.3.313","article-title":"Molecular genetics of drug resistance in Mycobacterium tuberculosis","volume":"34","author":"Zhang","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2013.01.007_bib0160","series-title":"Tuberculosis diagnostics automated DNA test. WHO endorsement and recommendations","author":"WHO","year":"2010"},{"key":"10.1016\/j.bjid.2013.01.007_bib0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2334-9-139","article-title":"Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda","volume":"9","author":"Ogwang","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0170","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2217\/fmb.11.84","article-title":"Xpert\u00ae MTB\/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance","volume":"6","author":"Lawn","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bjid.2013.01.007_bib0175","doi-asserted-by":"crossref","first-page":"e1001120","DOI":"10.1371\/journal.pmed.1001120","article-title":"Rapid diagnosis of tuberculosis with the Xpert MTB\/RIF assay in high burden countries: a cost-effectiveness analysis","volume":"8","author":"Vassall","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.bjid.2013.01.007_bib0180","first-page":"110","article-title":"Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains","volume":"15","author":"Al-Mutairi","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0185","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1128\/JCM.00138-11","article-title":"Suitability of Xpert MTB\/RIF and genotype MTBDRplus for patient selection for a tuberculosis clinical trial","volume":"49","author":"Friedrich","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2013.01.007_bib0190","first-page":"e3547","article-title":"Diagnosing pulmonary tuberculosis with the Xpert MTB\/RIF test","volume":"62","author":"Bodmer","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1016\/j.bjid.2013.01.007_bib0195","doi-asserted-by":"crossref","first-page":"e31563","DOI":"10.1371\/journal.pone.0031563","article-title":"Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis","volume":"7","author":"Tukvadze","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2013.01.007_bib0200","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.5588\/ijtld.11.0067","article-title":"Implementation of the INNO-LiPA Rif.TB\u00ae line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia","volume":"15","author":"Skenders","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0205","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1590\/S0074-02762011000500016","article-title":"Evaluation of rapid techniques for the detection of mycobacteria in sputum with scanty bacilli or clinically evident, smear negative cases of pulmonary and extra-pulmonary tuberculosis","volume":"106","author":"Pottathil","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.bjid.2013.01.007_bib0210","series-title":"Pathways to better diagnostics for tuberculosis. By the New Diagnostics Working Group of the Stop TB Partnership","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.bjid.2013.01.007_bib0215","series-title":"Rapid implementation of the Xpert MTB\/RIF diagnostic test. Technical and operational \u2018How-to\u2019. Practical considerations","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.bjid.2013.01.007_bib0220","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bjid.2013.01.007_bib0225","first-page":"1382","article-title":"Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative","volume":"8","author":"Nathanson","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa022928","article-title":"Community-based therapy for multidrug-resistant tuberculosis in Lima","volume":"348","author":"Mitnick","year":"2003","journal-title":"Peru N Engl J Med"},{"key":"10.1016\/j.bjid.2013.01.007_bib0235","first-page":"639","article-title":"Public-private collaboration for multidrug-resistant tuberculosis control in New York City","volume":"10","author":"Munsiff","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0240","first-page":"1314","article-title":"Adverse reactions among patients being treated for MDR-TB in Tomsk","volume":"11","author":"Shin","year":"2007","journal-title":"Russia Int J Tuberc Lung Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0245","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1371\/journal.pmed.0030241","article-title":"Cost-effectiveness of treating multidrug-resistant tuberculosis","volume":"3","author":"Resch","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.bjid.2013.01.007_bib0250","first-page":"186","article-title":"New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes","volume":"16","author":"Lienhardt","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.bjid.2013.01.007_bib0255","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(10)60359-9","article-title":"Global tuberculosis drug development pipeline: the need and the reality","volume":"375","author":"Ma","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2013.01.007_bib0260","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","article-title":"Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis","volume":"9","author":"Orenstein","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0265","first-page":"59","article-title":"Factors influencing the successful treatment of infectious pulmonary tuberculosis","volume":"11","author":"Chung","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0270","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1590\/S0102-35861999000200003","article-title":"Estudo de efetividade de esquemas alternativos para o tratamento da tuberculose multirresistente no Brasil","volume":"25","author":"Dalcolmo","year":"1999","journal-title":"J Pneumol"},{"key":"10.1016\/j.bjid.2013.01.007_bib0275","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1590\/S1806-37132009001000011","article-title":"III Diretrizes para Tuberculose da Sociedade Brasileira de Pneumologia e Tisiologia","volume":"35","author":"Conde","year":"2009","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.bjid.2013.01.007_bib0280","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(09)60333-0","article-title":"Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial","volume":"373","author":"Conde","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2013.01.007_bib0285","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Programa Nacional de Controle da Tuberculose (PNCT). Sistema de Informa\u00e7\u00e3o em Tuberculose Multirresistente (SITBMR). Available at: http:\/\/tbmr.ensp.fiocruz.br\/tbmr\/Relatorios."},{"key":"10.1016\/j.bjid.2013.01.007_bib0290","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1183\/09031936.00077307","article-title":"Clinical and operational value of the extensively drug-resistant tuberculosis definition","volume":"30","author":"Migliori","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bjid.2013.01.007_bib0295","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1183\/09031936.00168008","article-title":"Epidemiology and clinical management of XDR-TB: a systematic review by TBNET","volume":"33","author":"Sotgiu","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bjid.2013.01.007_bib0300","doi-asserted-by":"crossref","first-page":"e2957","DOI":"10.1371\/journal.pone.0002957","article-title":"Management of extensively drug-resistant tuberculosis in Peru: cure is possible","volume":"3","author":"Bonilla","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2013.01.007_bib0305","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","article-title":"Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study","volume":"375","author":"Dheda","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2013.01.007_bib0310","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jac\/dkp171","article-title":"Daily 300mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis","volume":"64","author":"Koh","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2013.01.007_bib0315","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1183\/09031936.00009509","article-title":"A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis","volume":"34","author":"Migliori","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bjid.2013.01.007_bib0320","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/648675","article-title":"Linezolid in the treatment of multidrug-resistant tuberculosis","volume":"50","author":"Schecter","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0325","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2165\/11532080-000000000-00000","article-title":"Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients","volume":"49","author":"Alffenaar","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bjid.2013.01.007_bib0330","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/dkq017","article-title":"Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000\u201306","volume":"65","author":"Anger","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2013.01.007_bib0335","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1183\/09031936.00195210","article-title":"Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis","volume":"38","author":"Villar","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bjid.2013.01.007_bib0340","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jac\/dkr500","article-title":"Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine","volume":"67","author":"Abbate","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2013.01.007_bib0345","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00076811","article-title":"Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India","volume":"39","author":"Singla","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bjid.2013.01.007_bib0350","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7883\/yoken.64.509","article-title":"Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis","volume":"64","author":"Tangg","year":"2011","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0355","first-page":"11","article-title":"Tratamento cir\u00fargico adjuvante de tuberculose pulmonar multirresistente","volume":"23","author":"Leite","year":"1997","journal-title":"J Pneumol"},{"key":"10.1016\/j.bjid.2013.01.007_bib0360","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12055-006-0500-5","article-title":"Surgical interventions in multidrug-resistant tuberculosis: retrospective analysis of 74 patients treated at a tertiary level care center","volume":"22","author":"Dewan","year":"2006","journal-title":"Ind J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bjid.2013.01.007_bib0365","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/thx.2005.051961","article-title":"Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima","volume":"62","author":"Somocurcio","year":"2007","journal-title":"Peru Thorax"},{"key":"10.1016\/j.bjid.2013.01.007_bib0370","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.athoracsur.2008.07.056","article-title":"Pulmonary resection in the treatment of multidrug-resistant tuberculosis: a retrospective study of 56 cases","volume":"86","author":"Wang","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bjid.2013.01.007_bib0375","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJMoa0800106","article-title":"Comprehensive treatment of extensively drug-resistant tuberculosis","volume":"359","author":"Mitnick","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2013.01.007_bib0380","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.ijid.2011.12.018","article-title":"Adjunctive surgery improves treatment outcomes among patients with multidrug-resistant and extensively drug-resistant tuberculosis","volume":"16","author":"Gegia","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0385","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jtcvs.2009.07.018","article-title":"Aggressive surgical treatment of multidrug-resistant tuberculosis","volume":"138","author":"Shiraishi","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bjid.2013.01.007_bib0390","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1183\/09031936.00047208","article-title":"Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis","volume":"34","author":"Dravniece","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bjid.2013.01.007_bib0395","series-title":"Global tuberculosis report 2012","author":"World Health Organization (WHO)","year":"2012"},{"key":"10.1016\/j.bjid.2013.01.007_bib0400","unstructured":"Stop TB Partnership Working Group on New TB Drugs. Available at: http:\/\/www.newtbdrugs.org."},{"issue":"Suppl. 2","key":"10.1016\/j.bjid.2013.01.007_bib0405","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1093\/infdis\/jis034","article-title":"New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future","volume":"205","author":"Lienhardt","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bjid.2013.01.007_bib0410","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/AAC.06126-11","article-title":"Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance","volume":"56","author":"Diacon","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2013.01.007_bib0415","unstructured":"Lounis N, Lounis E, De Paepe B, Van Baelen K, Andries K. A phase II, open-label trial with TMC207 as part of a multi-drug resistant tuberculosis (MDR-TB) treatment regimen in subjects with sputum smear-positive pulmonary infection with MDR-TB. Clinical Microbiology Report. Janssen Research and Development; 8 May 2012."},{"key":"10.1016\/j.bjid.2013.01.007_bib0420","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa1112433","article-title":"Delamanid for multidrug-resistant pulmonary tuberculosis","volume":"366","author":"Gler","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2013.01.007_bib0425","first-page":"21","article-title":"Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes","volume":"41","author":"Canetti","year":"1969","journal-title":"Bull World Health Organ"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S141386701300055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S141386701300055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T01:25:37Z","timestamp":1688088337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S141386701300055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S141386701300055X"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2013.01.007","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}